title: Cytological screening for cervical cancer--what are its opportunity costs?
authors.forename: B
authors.initials: B
authors.lastname: Bloch
authors.forename: L
authors.initials: L
authors.lastname: Denny
authors.forename: J
authors.initials: J
authors.lastname: Nevin
authors.forename: K
authors.initials: K
authors.lastname: Dehaeck
authors.forename: J
authors.initials: J
authors.lastname: Whittaker
authors.forename: R
authors.initials: R
authors.lastname: Soeters
mesh_terms: D005260:Female; D006292:Health Priorities; D006801:Humans; D008403:Mass Screening / Q000191:economics* / Q000592:standards; D009313:National Health Programs; D011786:Quality Control; D013019:South Africa; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*; D016387:Women's Health